NCT04743232View on ClinicalTrials.gov

COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment

NASuspendedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

January 31, 2025

Conditions
Covid19Cardiac Arrest
Interventions
OTHER

Decision tool for clinicians

Clinical decision aid, using a structured approach to advanced care directives and a comprehensive view of available risk scores.

Trial Locations (7)

1091AC

OLVG, Amsterdam

3079DZ

Maasstad Ziekenhuis, Rotterdam

Unknown

Amsterdam UMC, Amsterdam

Rijnstate, Arnhem

Medisch Spectrum Twente, Enschede

Radboud UMC, Nijmegen

3015CE

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER

NCT04743232 - COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment | Biotech Hunter | Biotech Hunter